These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 16678001)

  • 1. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing antimicrobial resistance in intensive care units.
    Gandhi TN; DePestel DD; Collins CD; Nagel J; Washer LL
    Crit Care Med; 2010 Aug; 38(8 Suppl):S315-23. PubMed ID: 20647789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment.
    Miyagawa CI
    New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving problems with resistant pathogens.
    Chastre J
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():3-14. PubMed ID: 18318874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.
    Arnold A; Brouse SD; Pitcher WD; Hall RG
    J Intensive Care Med; 2010 Sep; 25(5):259-70. PubMed ID: 20622257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial treatment of ventilator-associated pneumonia.
    Park DR
    Respir Care; 2005 Jul; 50(7):932-52; discussion 952-5. PubMed ID: 15972114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit.
    Hall CS; Ost DE
    Semin Respir Infect; 2003 Jun; 18(2):112-21. PubMed ID: 12840792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing use of aminoglycosides in the critically ill.
    Rea RS; Capitano B
    Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategies targeted at optimising antimicrobial therapy in critically ill patients].
    Eggimann P; Oddo M; Voirol P; Zanetti G; Chioléro R
    Rev Med Suisse; 2005 Dec; 1(45):2928-32. PubMed ID: 16425950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing bacterial resistance in surgical patients.
    Evans HL; Sawyer RG
    Surg Clin North Am; 2009 Apr; 89(2):501-19, x. PubMed ID: 19281897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
    Kollef MH
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S131-8. PubMed ID: 11017862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-resistant organisms in the neonatal intensive care unit.
    Bizzarro MJ; Gallagher PG
    Semin Perinatol; 2007 Feb; 31(1):26-32. PubMed ID: 17317424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.